Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 652 shares of the business's stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $46.00, for a total value of $29,992.00. Following the sale, the chief executive officer owned 44,067 shares in the company, valued at approximately $2,027,082. The trade was a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Thomas David Hull III also recently made the following trade(s):
- On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.34, for a total value of $35,047.82.
Kewaunee Scientific Price Performance
KEQU traded down $0.01 during trading on Monday, reaching $44.00. 4,425 shares of the stock were exchanged, compared to its average volume of 14,942. The business's 50 day moving average price is $54.22 and its two-hundred day moving average price is $45.51. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.32 and a quick ratio of 1.63. The company has a market capitalization of $126.28 million, a price-to-earnings ratio of 10.65 and a beta of 0.75. Kewaunee Scientific Corporation has a 1 year low of $30.33 and a 1 year high of $71.33.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its earnings results on Wednesday, September 10th. The technology company reported $1.10 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The company had revenue of $71.10 million for the quarter.
Hedge Funds Weigh In On Kewaunee Scientific
Several large investors have recently added to or reduced their stakes in KEQU. Jane Street Group LLC purchased a new position in Kewaunee Scientific during the fourth quarter worth about $300,000. Bank of America Corp DE lifted its position in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after buying an additional 443 shares during the period. Ritholtz Wealth Management lifted its position in Kewaunee Scientific by 42.2% during the first quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company's stock worth $707,000 after buying an additional 5,330 shares during the period. IFP Advisors Inc lifted its position in Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock worth $37,000 after buying an additional 360 shares during the period. Finally, American Century Companies Inc. lifted its position in Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company's stock worth $1,937,000 after buying an additional 14,889 shares during the period. 32.69% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th.
Read Our Latest Report on KEQU
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also

Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.